Allworth Financial LP Purchases 625 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Allworth Financial LP grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 40.2% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 2,179 shares of the medical instruments supplier’s stock after buying an additional 625 shares during the quarter. Allworth Financial LP’s holdings in DENTSPLY SIRONA were worth $59,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the company. First Eagle Investment Management LLC increased its position in DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after buying an additional 3,283,965 shares during the period. Nuance Investments LLC increased its position in DENTSPLY SIRONA by 3.8% during the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after buying an additional 402,329 shares during the period. Cooke & Bieler LP increased its position in DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after buying an additional 1,046,105 shares during the period. Price T Rowe Associates Inc. MD increased its position in DENTSPLY SIRONA by 5.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock worth $207,995,000 after buying an additional 343,915 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of DENTSPLY SIRONA by 42.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after purchasing an additional 1,308,411 shares during the period. Institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Stifel Nicolaus decreased their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research report on Thursday, July 18th. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research report on Monday, July 22nd. Barrington Research restated an “outperform” rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Evercore ISI decreased their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Finally, Needham & Company LLC decreased their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $32.67.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $23.49 on Friday. DENTSPLY SIRONA Inc. has a 12-month low of $22.85 and a 12-month high of $37.60. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The business’s 50-day moving average price is $25.12 and its two-hundred day moving average price is $26.27. The stock has a market cap of $4.76 billion, a PE ratio of -27.36, a P/E/G ratio of 1.28 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same period in the previous year, the business posted $0.51 earnings per share. The business’s revenue for the quarter was down 4.3% compared to the same quarter last year. As a group, analysts expect that DENTSPLY SIRONA Inc. will post 1.98 earnings per share for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.